Cargando…

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma

RATIONALE: A high risk of post‐operative recurrence contributes to the poor prognosis and low survival rate of oesophageal squamous cell carcinoma (ESCC) patients. Increasing experimental evidence suggests that integrin adhesion receptors, in particular integrin αv (ITGAV), are important for cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fangfang, Wu, Qiong, Han, Wei, Laster, Kyle, Hu, Yamei, Ma, Fayang, Chen, Hanyong, Tian, Xueli, Qiao, Yan, Liu, Hui, Kim, Dong Joon, Dong, Zigang, Liu, Kangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552524/ https://www.ncbi.nlm.nih.gov/pubmed/34709754 http://dx.doi.org/10.1002/ctm2.548

Ejemplares similares

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts
por: Ma, Fayang, et al.
Publicado: (2021)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
por: Tian, Xueli, et al.
Publicado: (2022)

The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations
por: Ma, Fayang, et al.
Publicado: (2022)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
por: Liu, Hui, et al.
Publicado: (2020)

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
por: Yin, Fanxiang, et al.
Publicado: (2022)

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
por: Zu, Xueyin, et al.
Publicado: (2020)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth
por: Xie, Xiaomeng, et al.
Publicado: (2021)

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
por: Sheng, Yuqiao, et al.
Publicado: (2016)

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway
por: Pang, Mengjun, et al.
Publicado: (2022)

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
por: Jia, Xuechao, et al.
Publicado: (2023)

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
por: Liu, Tingting, et al.
Publicado: (2020)

Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
por: Zhao, Ran, et al.
Publicado: (2020)

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model
por: Jin, Guoguo, et al.
Publicado: (2017)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2
por: Wang, Li, et al.
Publicado: (2018)

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
por: Bao, Zhuo, et al.
Publicado: (2022)

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
por: Yang, Ning, et al.
Publicado: (2022)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017)

3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
por: Fu, Xiaorong, et al.
Publicado: (2021)

Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19
por: Lu, Ning, et al.
Publicado: (2022)

Mechanism of inhibition of tumour growth by aspirin and indomethacin.
por: Lynch, N. R., et al.
Publicado: (1978)

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)

Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020)

Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer
por: Liu, Jihong, et al.
Publicado: (2019)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022)

Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1
por: Zhang, Man, et al.
Publicado: (2020)

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
por: Shin, Seung Ho, et al.
Publicado: (2017)

Inhibition of LTA4H by bestatin in human and mouse colorectal cancer
por: Zhao, Simin, et al.
Publicado: (2019)

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
por: Du, Ruijuan, et al.
Publicado: (2021)

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases
por: Song, Mengqiu, et al.
Publicado: (2023)

Effects of indomethacin on expression of PTEN tumour suppressor in human cancers
por: Abdulkareem, Imran Haruna, et al.
Publicado: (2013)

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model
por: Gu, Tingxuan, et al.
Publicado: (2021)

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
por: Zhang, Yi, et al.
Publicado: (2015)

Oesophageal squamous cell carcinoma mimicking submucosal tumour
por: Wang, Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r52146464h76b5dq7lf9e323im